Labcorp to Announce Second Quarter Financial Results on August 1, 2024
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
BURLINGTON, N.C., July 1, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
全球领先的创新和综合实验室服务供应商Labcorp (纽交所: LH) 将在2024年8月1日星期四美国东部时间上午9点(北京时间下午9点)公布2024年第二季度财务业绩。公司将于当天举行电话会议和网络直播以讨论业绩。关于财报的新闻稿和财务信息将发布在Labcorp投资者关系网站上。
The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.
电话会议将在Labcorp投资者关系网站上进行网络直播。参与者也可以通过单击此链接注册参加电话会议,以获得拨入号码和独特的个人识别码以接入电话会议。网络直播和拨入电话仅供听取。建议参与者提前10分钟加入,虽然参与者可以在电话会议期间随时注册并加入。
A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until July 18, 2025. To access the webcast recording, visit the Labcorp Investor Relations website.
直播的重播将于现场活动结束后约两个小时后提供,并可在2025年7月18日之前访问Labcorp投资者关系网站以访问直播的录像。
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at .
关于Labcorp
Labcorp (纽交所: LH)是全球领先的创新和综合实验室服务供应商,帮助医生、医院、制药公司、研究人员和患者做出明智而自信的决策。我们通过无与伦比的诊断和药物开发实验室能力提供洞察力,推进科学,改善健康和提高生活质量。公司的 67,000 名员工为约 100 个国家/地区的客户服务,在2023年为美国FDA批准的84%新药物和治疗产品提供支持,并为全球患者进行了超过6000万次的检测。请访问我们的网站了解更多信息。
SOURCE Labcorp Holdings Inc
Labcorp Holdings Inc的消息来源